glp-1 agonist gastroparesis Delayed Gastric Emptying: Clinical Implications and Management GASTROPARESIS RISK IN PATIENTS WITH

Slowing gastric emptying: GLP-1 also slows down the rate at which the stomach empties its contents into the small intestine

This increase of FFA in the liver and circulation results in hypertriglyceridemia, pronounced in the postprandial period, and fasting dyslipidemia leading to insulin resistance, obesity, and unfavorable changes to the cardiometabolic profile [10, 11]

According to a study by Obeid et al., a widely accepted expert consensus on diagnosing and treating vitamin B12 deficiency, recognized that untreated deficiency can lead to irreversible symptoms

3.3 Streptococcus spp

Patients with longstanding diabetes and established autonomic neuropathy face elevated baseline gastroparesis risk independent of GLP-1 use, making causality attribution particularly challenging in this population

In addition, IGF-1 LR3 enhances muscle growth and repair